Samuel J Holzmayer

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Samuel J Holzmayer, Joseph Kauer, Jonas Mauermann, Tobias Roider, Melanie Märklin
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts. Cancers 16 (7) (2024)
Sylwia Anna Stefańczyk, Ilona Hagelstein, Martina S Lutz, Stefanie Müller, Samuel J Holzmayer, Grace Jarjour, Latifa Zekri, Jonas S Heitmann, Helmut R Salih, Melanie Märklin
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody. Blood cancer journal 14 (1) (2024)
Sylwia Anna Stefańczyk, Ilona Hagelstein, Martina S Lutz, Stefanie Müller, Samuel J Holzmayer, Grace Jarjour, Latifa Zekri, Jonas S Heitmann, Helmut R Salih, Melanie Märklin
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody. Blood cancer journal 14 (1) (2024)
Sylwia Anna Stefańczyk, Ilona Hagelstein, Martina S Lutz, Stefanie Müller, Samuel J Holzmayer, Grace Jarjour, Latifa Zekri, Jonas S Heitmann, Helmut R Salih, Melanie Märklin
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody. Blood cancer journal 14 (1) (2024)
Sylwia Anna Stefańczyk, Ilona Hagelstein, Martina S Lutz, Stefanie Müller, Samuel J Holzmayer, Grace Jarjour, Latifa Zekri, Jonas S Heitmann, Helmut R Salih, Melanie Märklin
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody. Blood cancer journal 14 (1) (2024)
Sylwia Anna Stefańczyk, Ilona Hagelstein, Martina S Lutz, Stefanie Müller, Samuel J Holzmayer, Grace Jarjour, Latifa Zekri, Jonas S Heitmann, Helmut R Salih, Melanie Märklin
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody. Blood cancer journal 14 (1) (2024)
Samuel J Holzmayer, Joseph Kauer, Jonas Mauermann, Tobias Roider, Melanie Märklin
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts. Cancers 16 (7) (2024)
Samuel J Holzmayer, Joseph Kauer, Jonas Mauermann, Tobias Roider, Melanie Märklin
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts. Cancers 16 (7) (2024)